BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...to treat rare diseases, hired Steve Hughes as chief development officer. He was CMO of Organovo Holdings Inc....
BioCentury | Oct 3, 2019
Company News

Oct. 2 Company Quick Takes: Merck, Immunovant, PureTech-Ariya, Viscient-Organovo and Durect

...Viscient seeking merger with Organovo 3D tissue developer Viscient Biosciences Inc. proposed to merge with Organovo Holdings Inc....
...and Paul Bonanos, Associate Editors Keytruda, pembrolizumab (MK-3475, lambrolizumab) Merck & Co. Inc. Roivant Sciences Ltd. Durect Corp. PureTech Health plc Organovo Holdings Inc. Health...
BioCentury | May 30, 2019
Company News

May 30 Company Quick Takes: Unity in-licenses protein for cognitive decline, plus Astellas, Organovo, Iovance

..."FDA Approves Astellas' Xospata in FLT-3 Positive AML" ). Organovo shares surge following bioprinting collaboration Organovo Holdings Inc....
...KLA - Klotho α Jonathan Block, Associate Editor Xospata, gilteritinib (ASP2215) Astellas Pharma Inc. Chiesi Farmaceutici S.p.A. Inhibrx Inc. Iovance Biotherapeutics Inc. Organovo Holdings Inc. Unity...
BioCentury | Aug 1, 2018
Company News

Management tracks: Hologic, Tricidia

...David Price as CFO. He was CFO at Concordia International Corp. (TSX:CXR; NASDAQ:CXRX). Bioprinting company Organovo Holdings Inc....
BioCentury | Jan 4, 2018
Company News

Management tracks: Acceleron, Selecta

...aTyr Pharma Inc. (NASDAQ:LIFE). David was chief strategy officer and EVP of preclinical development at Organovo Holdings Inc....
BioCentury | Apr 12, 2017
Company News

Management tracks

...Bioprinting company Organovo Holdings Inc. (NASDAQ:ONVO) said CEO Keith Murphy will resign, effective April 21. Taylor Crouch, who...
BioCentury | Jan 6, 2017
Finance

Good riddance

...$5.0 $25.2 $29.1 15% Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (A) 10/26/16 $5.2 NA $18.4 NA Organovo Holdings Inc....
BioCentury | Oct 24, 2016
Financial News

Organovo Holdings completes follow-on

Organovo Holdings Inc. (NYSE-M:ONVO), San Diego, Calif. Business: Gene/Cell therapy, Supply/Service Date completed: 2016-10-20 Type: Follow-on Raised: $24.8 million Shares: 9 million Price: $2.75 Shares after offering: 101.7 million Underwriters: Jefferies; Evercore; Raymond James; BTIG...
BioCentury | Aug 8, 2016
Company News

Management tracks

...Wapnick as CFO. She was VP of finance at Amgen Inc. (NASDAQ:AMGN). Tissue modeling company Organovo Holdings Inc....
BioCentury | Jan 20, 2016
Company News

Management tracks

...Louis O'Dea CMO. O'Dea was CMO at Oxford Immunotec Global plc (NASDAQ:OXFD). Cell therapy play Organovo Holdings Inc....
Items per page:
1 - 10 of 35
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...to treat rare diseases, hired Steve Hughes as chief development officer. He was CMO of Organovo Holdings Inc....
BioCentury | Oct 3, 2019
Company News

Oct. 2 Company Quick Takes: Merck, Immunovant, PureTech-Ariya, Viscient-Organovo and Durect

...Viscient seeking merger with Organovo 3D tissue developer Viscient Biosciences Inc. proposed to merge with Organovo Holdings Inc....
...and Paul Bonanos, Associate Editors Keytruda, pembrolizumab (MK-3475, lambrolizumab) Merck & Co. Inc. Roivant Sciences Ltd. Durect Corp. PureTech Health plc Organovo Holdings Inc. Health...
BioCentury | May 30, 2019
Company News

May 30 Company Quick Takes: Unity in-licenses protein for cognitive decline, plus Astellas, Organovo, Iovance

..."FDA Approves Astellas' Xospata in FLT-3 Positive AML" ). Organovo shares surge following bioprinting collaboration Organovo Holdings Inc....
...KLA - Klotho α Jonathan Block, Associate Editor Xospata, gilteritinib (ASP2215) Astellas Pharma Inc. Chiesi Farmaceutici S.p.A. Inhibrx Inc. Iovance Biotherapeutics Inc. Organovo Holdings Inc. Unity...
BioCentury | Aug 1, 2018
Company News

Management tracks: Hologic, Tricidia

...David Price as CFO. He was CFO at Concordia International Corp. (TSX:CXR; NASDAQ:CXRX). Bioprinting company Organovo Holdings Inc....
BioCentury | Jan 4, 2018
Company News

Management tracks: Acceleron, Selecta

...aTyr Pharma Inc. (NASDAQ:LIFE). David was chief strategy officer and EVP of preclinical development at Organovo Holdings Inc....
BioCentury | Apr 12, 2017
Company News

Management tracks

...Bioprinting company Organovo Holdings Inc. (NASDAQ:ONVO) said CEO Keith Murphy will resign, effective April 21. Taylor Crouch, who...
BioCentury | Jan 6, 2017
Finance

Good riddance

...$5.0 $25.2 $29.1 15% Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (A) 10/26/16 $5.2 NA $18.4 NA Organovo Holdings Inc....
BioCentury | Oct 24, 2016
Financial News

Organovo Holdings completes follow-on

Organovo Holdings Inc. (NYSE-M:ONVO), San Diego, Calif. Business: Gene/Cell therapy, Supply/Service Date completed: 2016-10-20 Type: Follow-on Raised: $24.8 million Shares: 9 million Price: $2.75 Shares after offering: 101.7 million Underwriters: Jefferies; Evercore; Raymond James; BTIG...
BioCentury | Aug 8, 2016
Company News

Management tracks

...Wapnick as CFO. She was VP of finance at Amgen Inc. (NASDAQ:AMGN). Tissue modeling company Organovo Holdings Inc....
BioCentury | Jan 20, 2016
Company News

Management tracks

...Louis O'Dea CMO. O'Dea was CMO at Oxford Immunotec Global plc (NASDAQ:OXFD). Cell therapy play Organovo Holdings Inc....
Items per page:
1 - 10 of 35